A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used to detect or monitor the V617F mutation in the Janus kinase 2 (JAK2) gene in a clinical specimen. This mutation is associated with haematological abnormalities that may include essential thrombocythemia, polycythemia vera, primary myelofibrosis or leukaemia.